Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PNT - POINT Biopharma and Kinectrics ink long term Ytterbium-176 supply agreement

PNT - POINT Biopharma and Kinectrics ink long term Ytterbium-176 supply agreement

POINT Biopharma Global Inc.
POINT Biopharma (NASDAQ:PNT) and Kinectrics announce a long-term supply agreement for Ytterbium-176 (Yb-176) to support the company's in-house no-carrier added Lutetium-177 (n.c.a. Lu-177) production program. The input material for creating n.c.a. Lu-177 is Ytterbium-176 (Yb-176): a stable isotope precursor that is irradiated in nuclear reactors, producing Lu-177 through neutron activation. With the agreement with Kinectrics, POINT is laying the groundwork to access large quantities of highly enriched Yb-176, creating the world’s first, stable North American supply of n.c.a. Lu-177.

For further details see:

POINT Biopharma and Kinectrics ink long term Ytterbium-176 supply agreement
Stock Information
Company Name: POINT Biopharma Global Inc.
Stock Symbol: PNT
Market: NASDAQ
Website: pointbiopharma.com
Menu
PNT PNT Quote PNT Short PNT News PNT Articles PNT Message Board
Get PNT Alerts

News, Short Squeeze, Breakout and More Instantly...